Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel-XR for Neurocognitive Function in ARMS
NCT01250847Phase 4Unknown
- Sponsor
- Severance Hospital
- Start
- Nov 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in attenuated psychosis syndrome (APS), sponsored by Severance Hospital. Status: unknown.
02
Drugs
quetiapine
03
Conditions
attenuated psychosis syndrome (APS)
Beyond the preview
Go deeper on NCT01250847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250847.